Epigenetic abnormalities and reprogramming in epithelial-mesenchymal transition of lung adenocarcinoma
Project/Area Number |
26293080
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Human pathology
|
Research Institution | Jichi Medical University |
Principal Investigator |
Niki Toshiro 自治医科大学, 医学部, 教授 (90198424)
|
Co-Investigator(Kenkyū-buntansha) |
佐久間 裕司 札幌医科大学, 医学部, 准教授 (10364514)
吉本 多一郎 自治医科大学, 医学部, 講師 (20634166)
松原 大祐 自治医科大学, 医学部, 准教授 (80415554)
|
Project Period (FY) |
2014-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥15,990,000 (Direct Cost: ¥12,300,000、Indirect Cost: ¥3,690,000)
Fiscal Year 2017: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2016: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2014: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
|
Keywords | 肺腺癌 / 上皮間葉転換 / エピジェネティックス / 分化形質 / メチル化 / 肺癌 / エピジェネティクス |
Outline of Final Research Achievements |
About 20-30% of lung adenocarcinoma show loss of expression of TTF-1 (thyroid-specific transcription factor-1), a master regulator of lung development and differentiation. These adenocarcinomas frequently present with either mucinous or poorly differentiated solid morphology, features of epithelial-mesenchymal transition, and lack targetable driver mutations, such as EGFR and ALK. In this study, we have revealed that these characteristics of this subset of lung cancer may be causally related with 1) abnormalities of histone modifier expression, 2) loss of expression of chromatin remodelers BRG1/BRM, and inactivation of TTF-1 gene itself by gene mutation or methylation.
|
Academic Significance and Societal Importance of the Research Achievements |
ゲノム解析の進歩にも拘わらず、肺腺癌の20-30%では、治療標的となるドライバー変異がいまだ見出せていない。本研究によってもたらされた知見により、このような一群の肺腺癌におけるエピジェネティックス異常の重要性が認識され、今後の診断・治療開発に向けた研究が促進されることが期待される。
|
Report
(6 results)
Research Products
(30 results)
-
[Journal Article] Survivin knockdown induces senescence in TTF-1-expressing, KRAS-mutant lung adenocarcinomas.2018
Author(s)
Sumi T, Hirai S, Yamaguchi M, Tanaka Y, Tada M, Yamada G, Hasegawa T, Miyagi Y, Niki T, Watanabe A, Takahashi H, Sakuma Y.
-
Journal Title
International Journal of Oncology
Volume: 52
Pages: 33-46
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.2017
Author(s)
Yamaguchi M, Hirai S, Tanaka Y, Sumi T, Miyajima M, Mishina T, Yamada G, Otsuka M, Hasegawa T, Kojima T, Niki T, Watanabe A, Takahashi H, Sakuma Y.
-
Journal Title
Laboratory Investigation
Volume: 97
Pages: 232-242
Related Report
Peer Reviewed
-
[Journal Article] Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.2017
Author(s)
Nakano T, Kanai Y, Amano Y, Yoshimoto T, Matsubara D, Shibano T, Tamura T, Oguni S, Katashiba S, Ito T, Murakami Y, Fukayama M, Murakami T, Endo S, Niki T.
-
Journal Title
Plos One
Volume: 12
Issue: 8
Pages: e0181342-e0181342
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.2017
Author(s)
Matsubara D, Soda M, Yoshimoto T, Amano Y, Sakuma Y, Yamato A, Ueno T, Kojima S, Shibano T, Hosono Y, Kawazu M, Yamashita Y, Endo S, Hagiwara K, Fukayama M,Takahashi T, Mano H, Niki T.
-
Journal Title
Cancer Sci
Volume: 108
Issue: 9
Pages: 1888-1896
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Loss of YAP1 defines neuroendocrine differentiation of lung tumors.2016
Author(s)
Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y.
-
Journal Title
Cancer Science
Volume: 107
Issue: 10
Pages: 1527-1538
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma2015
Author(s)
Shin Saito, Kazue Morishima, Takashi Ui, Hiroko Hoshino, Daisuke Matsubara, Shumpei Ishikawa, Hiroyuki Aburatani, Masashi Fukayama, Yoshinori Hosoya, Naohiro Sato, Alan K Lefor, Yoshikazu Yasuda and Toshiro Niki
-
Journal Title
BMC cancer
Volume: 15
Issue: 1
Pages: 1-12
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.2014
Author(s)
Ui T, Morishima K, Saito S, Sakuma Y, Fujii H, Hosoya Y, Ishikawa S, Aburatani H, Fukayama M, Niki T, Yasuda Y.
-
Journal Title
Oncol Rep.
Volume: 31(2)
Issue: 2
Pages: 619-24
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.2014
Author(s)
Ibrahim R, Matsubara D, Osman W, Morikawa T, Goto A, Morita S, Ishikawa S, Aburatani H, Takai D, Nakajima J, Fukayama M, Niki T, Murakami Y
-
Journal Title
Hum Pathol.
Volume: 45
Issue: 7
Pages: 1397-405
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Stromal fibroblasts are predictors of disease-related mortality in esophageal squamous cell carcinoma.2014
Author(s)
Saito S, Morishima K, Ui T, Matsubara D, Tamura T, Oguni S, Hosoya Y, Sata N, Lefor AT, Yasuda Y, Niki T.
-
Journal Title
Oncology Reports
Volume: 32
Issue: 1
Pages: 348-354
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Presentation] Reciprocal expressions of TFF-1 and TTF-1 in lung adenocarcinomas.2018
Author(s)
Matsubara D, Soda M, Yoshimoto T, Amano Y, Kihara A, Sakuma Y, Endo S, Hagiwara K, Fukayama M, Mano H, Niki T.
Organizer
Annual Meeting of American Association for Cancer Research
Related Report
-
-
[Presentation] MUC21 is a candidate key molecule involved in the incohesive growth pattern of lung adenocarcinoma.2018
Author(s)
Yoshimoto T, Matsubara D, Soda M, Amano Y, Kihara A, Nakano T, Shibano T, Endo S, Hagiwara K, Denda-Nagai K, Irimura T, Mano H, Niki T.
Organizer
6th JCA-AACR Special Joint Conference
Related Report
-
-
-
-
-
-
-
-
-
-
[Presentation] Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.2014
Author(s)
24.Matsubara D, Ibrahim R, Osman W, Goto A, Morikawa T, Morita S, Ishikawa S, Aburatani H, Fukayama M, Niki T, Murakami Y.
Organizer
Annual Meeting of American Association for Cancer Research
Place of Presentation
San Diego
Year and Date
2014-04-05 – 2014-04-09
Related Report
-
-
-
-